FC
ELV icon

Fairscale Capital’s Elevance Health ELV Stock Holding History

Fairscale Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71K Hold
7
– – ﹤0.01% 375
2026
Q1 		$2.05K Hold
7
– – ﹤0.01% 387
2025
Q4 		$2.45K Sell
7
-58
-89% -$19.6K ﹤0.01% 368
2025
Q3 		$21K Hold
65
– – 0.01% 270
2025
Q2 		$18.4K Buy
65
+58
+829% +$23.3K 0.01% 278
2025
Q1 		$3.04K Hold
7
– – ﹤0.01% 288
2024
Q4 		$2.58K Hold
7
– – ﹤0.01% 294
2024
Q3 		$3.64K Hold
7
– – ﹤0.01% 286
2024
Q2 		$3.87K Buy
+7
New +$3.7K ﹤0.01% 284

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fairscale Capital's ELV Position: Q2 2026 in Review

Fairscale Capital held its Elevance Health (ELV) position steady in Q2 2026 at 7 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

Fairscale Capital first reported a position in ELV in Q2 2024 and has held it in 9 quarters since. The position peaked at $21K in Q3 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fairscale Capital held 7 shares of Elevance Health worth $2.71K as of Q2 2026.
  • Fairscale Capital left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Fairscale Capital's portfolio in Q2 2026, its #375 holding.
  • Fairscale Capital first reported a position in Elevance Health in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Elevance Health position peaked at $21K in Q3 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.